Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
抗生素和抗病毒
/
抗感染
结构
/
安莎霉素类
Antibacterial
/ Rifabutin/利福布汀

Rifabutin/利福布汀 {[allProObj[0].p_purity_real_show]}

货号：A878035 同义名： 利福布丁 / Ansamycin; LM-427

Rifabutin是一种半合成的安莎霉素类抗生素，抑制 DNA 依赖性 RNA 聚合酶，主要用于结核病的治疗及预防鸟分枝杆菌感染。

Rifabutin/利福布汀 化学结构 CAS号：72559-06-9
Rifabutin/利福布汀 化学结构
CAS号：72559-06-9
Rifabutin/利福布汀 3D分子结构
CAS号：72559-06-9
Rifabutin/利福布汀 化学结构 CAS号：72559-06-9
Rifabutin/利福布汀 3D分子结构 CAS号：72559-06-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Rifabutin/利福布汀 纯度/质量文件 产品仅供科研

货号：A878035 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
• Nat. Electron., 2025, 8, 66-74. Ambeed. [ A100095 ]
• Adv. Mater., 2025, 2416621. Ambeed. [ A255324 , A420052 ]
• Adv. Mater., 2025, 2410493. Ambeed. [ A838608 ]
• Adv. Mater., 2025, 2420319. Ambeed. [ A106129 ]
更多 >

Rifabutin/利福布汀 生物活性

描述 Rifabutin (RBT) is the rifamycin that is recommended to treat tuberculosis (TB) in HIV-infected individuals during combination antiretroviral therapy (ART) containing HIV protease inhibitors (PIs)[3]. Rifabutin is a rifamycin with activity against Mycobacterium tuberculosis. RFB is well tolerated by patients who develop RMP-related (Rifampin) AEs (adverse effects)[4]. Rifabutin at 16 μg/mL was only bacteriostatic (MIC of 4 μg/mL) and was moderately synergistic in combination with imipenem (fractional inhibitory concentration [FIC] index of 0.38). Addition of rifabutin (16 μg/mL) moderately increased killing by a low (8 μg/mL) but not by a high (32 μg/mL) concentration of imipenem. In infected macrophages, rifabutin (16 μg/mL) increased the activity of imipenem at 8 and 32 μg/mL, achieving 3- and 100-fold reductions in the numbers of intracellular bacteria, respectively[5]. The use of rifabutin can improve treatment outcomes in patients with rifabutin-sensitive MDR-TB[6]. In addition, the combination of rifabutin plus bedaquiline produces sustained intracellular mycobactericidal activity that is greater than the sum of their individual effects[7].

Rifabutin/利福布汀 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02024555 Sarcoidosis; Antimycobacterial... 展开 >> Therapy 收起 << Phase 2 Recruiting May 2019 United States, New York ... 展开 >> Albany Medical Center Recruiting Albany, New York, United States, 12208 Contact: Marc Judson, MD    518-262-5196    judsonm@mail.amc.edu    Contact: Leahruth Saavedra, MS    (518) 262-0355    saavedl@amc.edu    Sub-Investigator: Marc Judson, MD          United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Robert Baughman, MD    513-584-5110    bob.baughman@ucmail.uc.edu    Contact: Joyce Zeigler    (513) 584-6252    zeiglejm@ucmail.uc.edu    Principal Investigator: Robert Baughman, MD          Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Dan Culver, DO    216-444-6508    culverd@ccf.org    Contact: Allison Wimer    216-444-9975    wimera@ccf.org    Principal Investigator: Dan Culver, DO          Ohio State University Recruiting Columbus, Ohio, United States, 43221 Contact: Elliott Crouser, M.D.    614-293-4925    elliott.crouser@osumc.edu    Contact: Karen Martin    614-293-4978    karen.martin@osumc.edu    Sub-Investigator: Elliott Crouser, M.D.          United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Ennis James, MD    843-792-3769    jamesw@musc.edu    Contact: Robyn Do    (843) 792-1221    dorobyn@musc.edu    Sub-Investigator: Ennis James, MD          United States, Tennessee Vanderbilt University School of Medicine Recruiting Nashville, Tennessee, United States, 37232 Contact: Wonder Drake, MD    615-322-2035    wonder.drake@vanderbilt.edu    Contact: Amy Kerrigan, MSN    615-343-3238    amy.kerrigan@vanderbilt.edu    Principal Investigator: Wonder Drake, MD 收起 <<
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... 展开 >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD 收起 <<
NCT01951326 Crohn's Disease Phase 3 Active, not recruiting April 2019 -

Rifabutin/利福布汀 参考文献

[1]Katoh M, Watanabe M, et al. In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver. Xenobiotica. 2005 Sep;35(9):863-75.

[2]Kunin CM. Antimicrobial activity of rifabutin. Clin Infect Dis. 1996 Apr;22 Suppl 1:S3-13; discussion S13-4.

[3]Ramachandran G, Hemanth Kumar AK, Kannan T, et al. Pharmacokinetics of rifabutin during atazanavir/ritonavir co-administration in HIV-infected TB patients. Indian J Tuberc. 2019;66(1):129–133

[4]Horne DJ, Spitters C, Narita M. Experience with rifabutin replacing rifampin in the treatment of tuberculosis. Int J Tuberc Lung Dis. 2011;15(11):1485–i

[5]Le Run E, Arthur M, Mainardi JL. In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. Antimicrob Agents Chemother. 2018;62(8):e00623-18.

[6]Lee H, Ahn S, Hwang NY, et al. Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis. Int J Infect Dis. 2017;65:135–141

[7]Wallis RS, Good CE, O'Riordan MA, et al. Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial. PLoS One. 2018;13(5):e0196756. Published 2018 May 2

Rifabutin/利福布汀 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.18mL

0.24mL

0.12mL

5.90mL

1.18mL

0.59mL

11.81mL

2.36mL

1.18mL

Rifabutin/利福布汀 技术信息

CAS号72559-06-9
分子式C46H62N4O11
分子量 847.0
SMILES Code C[C@@]1(O2)O/C=C/[C@@H]([C@H]([C@H]([C@H](C)[C@H](O)[C@H](C)[C@H]([C@H](/C=C/C=C(C(NC(C3=O)=C4NC5(CCN(CC(C)C)CC5)N=C4C6=C3C(O)=C(C)C2=C6C1=O)=O)\C)C)O)OC(C)=O)C)OC
MDL No. MFCD00866816
别名 利福布丁 ;Ansamycin; LM-427; Rifabutina; Mycobutin
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C
溶解方案

DMSO: 50 mg/mL(59.03 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

Tags: Rifabutin | Ansamycin;LM-427;Rifabutina;Mycobutin | 利福布丁 | Ansamycin | Antibacterial | AmBeed-信号通路专用抑制剂 | Rifabutin/利福布汀 纯度/质量文件 | Rifabutin/利福布汀 生物活性 | Rifabutin/利福布汀 临床数据 | Rifabutin/利福布汀 参考文献 | Rifabutin/利福布汀 实验方案 | Rifabutin/利福布汀 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z